Risk factors and prediction of myocardial infarction
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 1, 2016
Grant Date -
Jun 9, 2011
app pub date -
Nov 15, 2010
filing date -
Nov 13, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Biomarkers and methods are disclosed for diagnosing the risk of a myocardial infarction in an individual by measuring the levels of a set of biomarkers in a sample from an individual. A risk score is calculated for the individual by weighting the measured levels of the biomarkers. The risk score then is used to identify whether the individual is likely to experience a myocardial infarction. In addition, kits are disclosed that include a set of reagents for specifically measuring biomarker levels in a sample from an individual.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully